News tagged with pharmaceutical

Surgeon variation affects QoL after prostatectomy

(HealthDay)—There is a significant association between performing surgeons and patient quality of life following radical prostatectomy, according to a study published in the April issue of The Journal of ...

May 15, 2013
popularity not rated yet | comments 0

Renaissance in new drugs for rare diseases

Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, ...

May 13, 2013
popularity not rated yet | comments 0

Victims: Thalidomide sold in Spain post-withdrawal

(AP)—Spanish victims of thalidomide on Wednesday published documents they claim prove a German drug company kept distributing the notorious drug in Spain six months after it was taken off the market in other countries.

May 08, 2013
popularity not rated yet | comments 0

Unethical advertising at launch of antidepressants

The new feature of the antidepressant drugs of the 1990s was that they had milder side-effects than their predecessors. Combined with aggressive marketing, this meant that annual sales in Sweden increased from just under ...

May 02, 2013
popularity not rated yet | comments 0

Lundbeck profit jumps but warns on generic pressure

Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.

May 01, 2013
popularity not rated yet | comments 0

Report updates impact of hypoglycemia in diabetes

(HealthDay)—An update of the current state of knowledge about the impact of hypoglycemia on patients with diabetes reviews outcomes, strategies to prevent hypoglycemia, and current knowledge gaps, and has ...

Apr 26, 2013
popularity 5 / 5 (1) | comments 0

Bayer profits up 11.5 percent on new drugs

German chemical and pharmaceutical company Bayer AG said Thursday that its net profit rose 11.5 percent in the first quarter as new drugs, led by blood thinner Xarelto, boosted sales.

Apr 25, 2013
popularity not rated yet | comments 0